Prezzo delle Azioni

Data	Amneal Pharmaceuticals Ricavi	Amneal Pharmaceuticals EBIT	Amneal Pharmaceuticals Guadagno
2028e	2,83 miliardi undefined	0 undefined	289,64 Mio. undefined
2027e	2,74 miliardi undefined	420,44 Mio. undefined	261,30 Mio. undefined
2026e	2,82 miliardi undefined	553,96 Mio. undefined	218,28 Mio. undefined
2025e	2,71 miliardi undefined	528,39 Mio. undefined	203,06 Mio. undefined
2024e	2,61 miliardi undefined	515,55 Mio. undefined	182,60 Mio. undefined
2023	2,39 miliardi undefined	274,85 Mio. undefined	-83,99 Mio. undefined
2022	2,21 miliardi undefined	199,30 Mio. undefined	-129,99 Mio. undefined
2021	2,09 miliardi undefined	216,40 Mio. undefined	10,62 Mio. undefined
2020	1,99 miliardi undefined	145,70 Mio. undefined	91,10 Mio. undefined
2019	1,63 miliardi undefined	-12,70 Mio. undefined	-361,90 Mio. undefined
2018	1,66 miliardi undefined	284,50 Mio. undefined	-20,90 Mio. undefined
2017	775,80 Mio. undefined	-153,30 Mio. undefined	-469,30 Mio. undefined
2016	824,40 Mio. undefined	-433,40 Mio. undefined	-472,00 Mio. undefined
2015	860,50 Mio. undefined	87,90 Mio. undefined	39,00 Mio. undefined
2014	596,00 Mio. undefined	97,00 Mio. undefined	57,40 Mio. undefined
2013	511,50 Mio. undefined	24,10 Mio. undefined	101,30 Mio. undefined
2012	581,70 Mio. undefined	97,20 Mio. undefined	55,90 Mio. undefined
2011	512,90 Mio. undefined	107,10 Mio. undefined	65,50 Mio. undefined
2010	879,50 Mio. undefined	399,70 Mio. undefined	250,40 Mio. undefined
2009	358,40 Mio. undefined	85,10 Mio. undefined	50,10 Mio. undefined
2008	210,10 Mio. undefined	10,40 Mio. undefined	16,00 Mio. undefined
2007	273,80 Mio. undefined	86,50 Mio. undefined	125,40 Mio. undefined
2006	135,20 Mio. undefined	1,00 Mio. undefined	-12,00 Mio. undefined
2005	112,40 Mio. undefined	2,10 Mio. undefined	-5,80 Mio. undefined
2003	58,80 Mio. undefined	-13,50 Mio. undefined	-14,20 Mio. undefined

	Ricavi	EBIT	Guadagno
2003	58,80 Mio. USD	-13,50 Mio. USD	-14,20 Mio. USD
2005	112,40 Mio. USD	2,10 Mio. USD	-5,80 Mio. USD
2006	135,20 Mio. USD	1,00 Mio. USD	-12,00 Mio. USD
2007	273,80 Mio. USD	86,50 Mio. USD	125,40 Mio. USD
2008	210,10 Mio. USD	10,40 Mio. USD	16,00 Mio. USD
2009	358,40 Mio. USD	85,10 Mio. USD	50,10 Mio. USD
2010	879,50 Mio. USD	399,70 Mio. USD	250,40 Mio. USD
2011	512,90 Mio. USD	107,10 Mio. USD	65,50 Mio. USD
2012	581,70 Mio. USD	97,20 Mio. USD	55,90 Mio. USD
2013	511,50 Mio. USD	24,10 Mio. USD	101,30 Mio. USD
2014	596,00 Mio. USD	97,00 Mio. USD	57,40 Mio. USD
2015	860,50 Mio. USD	87,90 Mio. USD	39,00 Mio. USD
2016	824,40 Mio. USD	-433,40 Mio. USD	-472,00 Mio. USD
2017	775,80 Mio. USD	-153,30 Mio. USD	-469,30 Mio. USD
2018	1,66 miliardi USD	284,50 Mio. USD	-20,90 Mio. USD
2019	1,63 miliardi USD	-12,70 Mio. USD	-361,90 Mio. USD
2020	1,99 miliardi USD	145,70 Mio. USD	91,10 Mio. USD
2021	2,09 miliardi USD	216,40 Mio. USD	10,62 Mio. USD
2022	2,21 miliardi USD	199,30 Mio. USD	-129,99 Mio. USD
2023	2,39 miliardi USD	274,85 Mio. USD	-83,99 Mio. USD
2024e	2,61 miliardi USD	515,55 Mio. USD	182,60 Mio. USD
2025e	2,71 miliardi USD	528,39 Mio. USD	203,06 Mio. USD
2026e	2,82 miliardi USD	553,96 Mio. USD	218,28 Mio. USD
2027e	2,74 miliardi USD	420,44 Mio. USD	261,30 Mio. USD
2028e	2,83 miliardi USD	0 USD	289,64 Mio. USD

Amneal Pharmaceuticals Margine lordo	Amneal Pharmaceuticals Margine di profitto	Amneal Pharmaceuticals Margine EBIT	Amneal Pharmaceuticals Margine di profitto
2028e	35,79 %	0 %	10,25 %
2027e	35,79 %	15,33 %	9,53 %
2026e	35,79 %	19,64 %	7,74 %
2025e	35,79 %	19,52 %	7,50 %
2024e	35,79 %	19,75 %	6,99 %
2023	35,79 %	11,48 %	-3,51 %
2022	35,97 %	9,01 %	-5,88 %
2021	37,81 %	10,34 %	0,51 %
2020	33,27 %	7,31 %	4,57 %
2019	29,46 %	-0,78 %	-22,25 %
2018	43,62 %	17,11 %	-1,26 %
2017	18,54 %	-19,76 %	-60,49 %
2016	-18,33 %	-52,57 %	-57,25 %
2015	41,80 %	10,21 %	4,53 %
2014	52,95 %	16,28 %	9,63 %
2013	41,54 %	4,71 %	19,80 %
2012	48,58 %	16,71 %	9,61 %
2011	50,36 %	20,88 %	12,77 %
2010	61,32 %	45,45 %	28,47 %
2009	52,48 %	23,74 %	13,98 %
2008	56,21 %	4,95 %	7,62 %
2007	60,66 %	31,59 %	45,80 %
2006	46,60 %	0,74 %	-8,88 %
2005	48,04 %	1,87 %	-5,16 %
2003	25,51 %	-22,96 %	-24,15 %

	Margine lordo	Margine EBIT	Margine di profitto
2003	25,51 %	-22,96 %	-24,15 %
2005	48,04 %	1,87 %	-5,16 %
2006	46,60 %	0,74 %	-8,88 %
2007	60,66 %	31,59 %	45,80 %
2008	56,21 %	4,95 %	7,62 %
2009	52,48 %	23,74 %	13,98 %
2010	61,32 %	45,45 %	28,47 %
2011	50,36 %	20,88 %	12,77 %
2012	48,58 %	16,71 %	9,61 %
2013	41,54 %	4,71 %	19,80 %
2014	52,95 %	16,28 %	9,63 %
2015	41,80 %	10,21 %	4,53 %
2016	-18,33 %	-52,57 %	-57,25 %
2017	18,54 %	-19,76 %	-60,49 %
2018	43,62 %	17,11 %	-1,26 %
2019	29,46 %	-0,78 %	-22,25 %
2020	33,27 %	7,31 %	4,57 %
2021	37,81 %	10,34 %	0,51 %
2022	35,97 %	9,01 %	-5,88 %
2023	35,79 %	11,48 %	-3,51 %
2024e	35,79 %	19,75 %	6,99 %
2025e	35,79 %	19,52 %	7,50 %
2026e	35,79 %	19,64 %	7,74 %
2027e	35,79 %	15,33 %	9,53 %
2028e	35,79 %	0 %	10,25 %

Data	Amneal Pharmaceuticals Ricavi per azione	Amneal Pharmaceuticals EBIT per azione	Amneal Pharmaceuticals Utile per azione
2028e	9,16 undefined	0 undefined	0,94 undefined
2027e	8,88 undefined	0 undefined	0,85 undefined
2026e	9,14 undefined	0 undefined	0,71 undefined
2025e	8,77 undefined	0 undefined	0,66 undefined
2024e	8,46 undefined	0 undefined	0,59 undefined
2023	13,59 undefined	1,56 undefined	-0,48 undefined
2022	14,66 undefined	1,32 undefined	-0,86 undefined
2021	13,79 undefined	1,43 undefined	0,07 undefined
2020	13,38 undefined	0,98 undefined	0,61 undefined
2019	12,31 undefined	-0,10 undefined	-2,74 undefined
2018	13,06 undefined	2,23 undefined	-0,16 undefined
2017	10,79 undefined	-2,13 undefined	-6,53 undefined
2016	11,59 undefined	-6,10 undefined	-6,64 undefined
2015	11,95 undefined	1,22 undefined	0,54 undefined
2014	8,45 undefined	1,38 undefined	0,81 undefined
2013	7,45 undefined	0,35 undefined	1,47 undefined
2012	8,50 undefined	1,42 undefined	0,82 undefined
2011	7,62 undefined	1,59 undefined	0,97 undefined
2010	13,41 undefined	6,09 undefined	3,82 undefined
2009	5,87 undefined	1,39 undefined	0,82 undefined
2008	3,46 undefined	0,17 undefined	0,26 undefined
2007	4,47 undefined	1,41 undefined	2,05 undefined
2006	2,29 undefined	0,02 undefined	-0,20 undefined
2005	1,91 undefined	0,04 undefined	-0,10 undefined
2003	1,15 undefined	-0,26 undefined	-0,28 undefined

	Ricavi per azione	EBIT per azione	Utile per azione
2003	1,15 USD	-0,26 USD	-0,28 USD
2005	1,91 USD	0,04 USD	-0,10 USD
2006	2,29 USD	0,02 USD	-0,20 USD
2007	4,47 USD	1,41 USD	2,05 USD
2008	3,46 USD	0,17 USD	0,26 USD
2009	5,87 USD	1,39 USD	0,82 USD
2010	13,41 USD	6,09 USD	3,82 USD
2011	7,62 USD	1,59 USD	0,97 USD
2012	8,50 USD	1,42 USD	0,82 USD
2013	7,45 USD	0,35 USD	1,47 USD
2014	8,45 USD	1,38 USD	0,81 USD
2015	11,95 USD	1,22 USD	0,54 USD
2016	11,59 USD	-6,10 USD	-6,64 USD
2017	10,79 USD	-2,13 USD	-6,53 USD
2018	13,06 USD	2,23 USD	-0,16 USD
2019	12,31 USD	-0,10 USD	-2,74 USD
2020	13,38 USD	0,98 USD	0,61 USD
2021	13,79 USD	1,43 USD	0,07 USD
2022	14,66 USD	1,32 USD	-0,86 USD
2023	13,59 USD	1,56 USD	-0,48 USD
2024e	8,46 USD	0 USD	0,59 USD
2025e	8,77 USD	0 USD	0,66 USD
2026e	9,14 USD	0 USD	0,71 USD
2027e	8,88 USD	0 USD	0,85 USD
2028e	9,16 USD	0 USD	0,94 USD

	Numero di Azioni
2003	51,30 Mio. Aktien
2005	59,00 Mio. Aktien
2006	59,00 Mio. Aktien
2007	61,20 Mio. Aktien
2008	60,80 Mio. Aktien
2009	61,10 Mio. Aktien
2010	65,60 Mio. Aktien
2011	67,30 Mio. Aktien
2012	68,40 Mio. Aktien
2013	68,70 Mio. Aktien
2014	70,50 Mio. Aktien
2015	72,00 Mio. Aktien
2016	71,10 Mio. Aktien
2017	71,90 Mio. Aktien
2018	127,30 Mio. Aktien
2019	132,10 Mio. Aktien
2020	148,90 Mio. Aktien
2021	151,82 Mio. Aktien
2022	150,94 Mio. Aktien
2023	176,14 Mio. Aktien
2024e	176,14 Mio. Aktien
2025e	176,14 Mio. Aktien
2026e	176,14 Mio. Aktien
2027e	176,14 Mio. Aktien
2028e	176,14 Mio. Aktien

Data	Stima EPS	EPS attuale	Trimestre del rapporto
30/09/2023	0,13	0,19 (46,95 %)	2023 Q3
30/06/2023	0,11	0,19 (75,76 %)	2023 Q2
31/03/2023	0,10	0,12 (22,57 %)	2023 Q1
31/12/2022	0,21	0,23 (7,73 %)	2022 Q4
30/09/2022	0,18	0,14 (-22,39 %)	2022 Q3
30/06/2022	0,20	0,19 (-4,14 %)	2022 Q2
31/03/2022	0,13	0,12 (-9,02 %)	2022 Q1
31/12/2021	0,20	0,18 (-11,24 %)	2021 Q4
30/09/2021	0,21	0,21 (0,77 %)	2021 Q3
30/06/2021	0,19	0,25 (33,40 %)	2021 Q2
31/03/2021	0,18	0,20 (11,17 %)	2021 Q1
31/12/2020	0,14	0,14 (2,04 %)	2020 Q4
30/09/2020	0,12	0,16 (28,72 %)	2020 Q3
30/06/2020	0,10	0,13 (31,85 %)	2020 Q2
31/03/2020	0,09	0,20 (120,02 %)	2020 Q1
31/12/2019	0,05	0,08 (55,04 %)	2019 Q4
30/09/2019	0,14	0,04 (-71,43 %)	2019 Q3
30/06/2019	0,14	0,09 (-35,02 %)	2019 Q2
31/03/2019	0,18	0,14 (-22,57 %)	2019 Q1
31/12/2018	0,28	0,33 (18,62 %)	2018 Q4
30/09/2018	0,28	0,28 (-0,04 %)	2018 Q3
30/06/2018	0,23	0,24 (5,03 %)	2018 Q2
31/03/2018	0,17	0,14 (-17,21 %)	2018 Q1
31/12/2017	0,12	0,11 (-4,84 %)	2017 Q4
30/09/2017	0,20	0,23 (14,37 %)	2017 Q3
30/06/2017	0,14	0,18 (24,65 %)	2017 Q2
31/03/2017	0,13	0,11 (-15,97 %)	2017 Q1
31/12/2016	0,16	0,16 (0,82 %)	2016 Q4
30/09/2016	0,39	0,37 (-5,71 %)	2016 Q3
30/06/2016	0,33	0,21 (-35,54 %)	2016 Q2
31/03/2016	0,40	0,43 (7,45 %)	2016 Q1
31/12/2015	0,44	0,62 (39,36 %)	2015 Q4
30/09/2015	0,39	0,40 (1,42 %)	2015 Q3
30/06/2015	0,36	0,34 (-4,97 %)	2015 Q2
31/03/2015	0,18	0,09 (-50,14 %)	2015 Q1
31/12/2014	0,12	0,16 (32,34 %)	2014 Q4
30/09/2014	0,31	0,33 (4,93 %)	2014 Q3
30/06/2014	0,37	0,60 (63,40 %)	2014 Q2
31/03/2014	0,05	0,24 (380,96 %)	2014 Q1
31/12/2013	0,03	-0,02 (-158,82 %)	2013 Q4
30/09/2013	-0,07	0,25 (455,62 %)	2013 Q3
30/06/2013	0,04	0,23 (441,18 %)	2013 Q2
31/03/2013	0,21	0,37 (79,96 %)	2013 Q1
31/12/2012	0,19	0,30 (56,09 %)	2012 Q4
30/09/2012	0,51	0,48 (-5,34 %)	2012 Q3
30/06/2012	0,45	0,60 (31,96 %)	2012 Q2
31/03/2012	0,50	0,55 (9,37 %)	2012 Q1
31/12/2011	0,22	0,36 (61,22 %)	2011 Q4
30/09/2011	0,23	0,30 (29,76 %)	2011 Q3
30/06/2011	0,19	0,22 (13,52 %)	2011 Q2
31/03/2011	0,15	0,24 (61,18 %)	2011 Q1
31/12/2010	0,22	0,23 (2,50 %)	2010 Q4
30/09/2010	0,26	0,24 (-8,71 %)	2010 Q3
30/06/2010	0,52	0,48 (-7,32 %)	2010 Q2
31/03/2010	0,52	2,06 (298,92 %)	2010 Q1
31/12/2009	0,15	0,69 (373,58 %)	2009 Q4
30/09/2009	0,05	0,11 (139,65 %)	2009 Q3
30/06/2009	0,03	0,05 (63,40 %)	2009 Q2
31/03/2009	-0,07	0,04 (156,02 %)	2009 Q1
30/09/2004	0,05	0,01 (-80,88 %)	2004 Q3
30/06/2004	0,03	0,01 (-62,26 %)	2004 Q2
31/03/2004	-0,03	0,14 (557,52 %)	2004 Q1
31/12/2003	-0,05	-0,05 (6,72 %)	2003 Q4
30/09/2003	-0,03	-0,07 (-174,51 %)	2003 Q3
30/06/2003	-0,06	-0,05 (18,30 %)	2003 Q2
31/03/2003	-0,09	-0,07 (19,26 %)	2003 Q1
31/12/2002	-0,11	-0,07 (36,19 %)	2002 Q4
30/09/2002	-0,13	-0,11 (17,04 %)	2002 Q3
30/06/2002	-0,12	-0,13 (-8,42 %)	2002 Q2
31/03/2002	-0,14	-0,12 (11,24 %)	2002 Q1
31/12/2001	-0,15	-0,15 (-1,42 %)	2001 Q4
30/09/2001	-0,14	-0,15 (-7,60 %)	2001 Q3
30/06/2001	-0,18	-0,15 (18,30 %)	2001 Q2
31/03/2001	-0,21	-0,16 (25,30 %)	2001 Q1
31/12/2000	-0,23	-0,20 (14,75 %)	2000 Q4
30/06/2000	-0,18	-0,21 (-14,38 %)	2000 Q2

%	Nome	Azioni	Variazione	Data
6,97 %	Fosun International Ltd	21.521.301	0	30/06/2023
4,30 %	Patel (Gautam)	13.261.751	0	16/10/2023
4,22 %	The Vanguard Group, Inc.	13.013.152	-128.629	30/06/2023
3,99 %	TPG Capital, L.P.	12.328.767	0	30/06/2023
2,34 %	BlackRock Institutional Trust Company, N.A.	7.224.433	1.020.970	30/06/2023
1,71 %	Eversept Partners, LP	5.265.251	82.205	30/06/2023
1,21 %	Neuberger Berman, LLC	3.747.939	65.312	30/06/2023
0,88 %	Norges Bank Investment Management (NBIM)	2.714.400	2.714.400	31/12/2022
0,84 %	Rubric Capital Management LP	2.601.379	2.601.379	30/06/2023
0,72 %	State Street Global Advisors (US)	2.230.737	100.768	30/06/2023
0,71 %	Geode Capital Management, L.L.C.	2.194.991	319.268	30/06/2023
0,70 %	AQR Capital Management, LLC	2.156.242	-854.660	30/06/2023
0,70 %	Nantahala Capital Management, LLC	2.149.305	1.649.305	30/06/2023
0,42 %	LSV Asset Management	1.293.200	-104.000	30/06/2023
0,41 %	Charles Schwab Investment Management, Inc.	1.255.034	96.631	30/06/2023
0,40 %	PGIM Quantitative Solutions LLC	1.239.176	209.060	30/06/2023
0,39 %	Dimensional Fund Advisors, L.P.	1.198.110	-143.693	30/06/2023
0,39 %	Citadel Advisors LLC	1.195.508	160.305	30/06/2023
0,33 %	Millennium Management LLC	1.028.641	-2.065.044	30/06/2023
0,32 %	Nuveen LLC	998.218	700.648	30/06/2023
0,30 %	Northern Trust Investments, Inc.	931.785	71.571	30/06/2023
0,30 %	Arrowstreet Capital, Limited Partnership	912.974	231.957	30/06/2023
0,27 %	Two Sigma Investments, LP	835.235	324.493	30/06/2023
0,23 %	Teacher Retirement System of Texas	720.101	114.899	30/06/2023
0,20 %	Allspring Global Investments, LLC	625.479	-1.283.443	30/06/2023
0,20 %	D. E. Shaw & Co., L.P.	622.226	-7.883	30/06/2023
0,20 %	Meister Paul M	620.658	112.179	10/05/2023
0,17 %	Patel (Chirag K)	512.566	0	16/10/2023
0,17 %	Patel (Chintu)	512.566	0	16/10/2023
0,16 %	JP Morgan Asset Management	508.025	193.064	30/06/2023
0,13 %	Brandywine Global Investment Management, LLC	401.680	401.680	30/06/2023
0,12 %	Connor, Clark & Lunn Investment Management Ltd.	385.214	54.717	30/06/2023
0,12 %	Konidaris (Anastasios G)	380.840	169.205	13/03/2023
0,12 %	Invesco Capital Management LLC	364.809	-2.500	30/06/2023
0,11 %	BlackRock Investment Management, LLC	331.954	59.111	30/06/2023
0,11 %	BlackRock Financial Management, Inc.	331.759	-230.477	30/06/2023
0,11 %	Todisco (Joseph)	327.194	2.880	07/05/2022
0,10 %	Shah (Nikita)	319.972	36.796	13/03/2023
0,10 %	Mellon Investments Corporation	316.961	121.206	30/06/2023
0,10 %	Goldman Sachs Asset Management, L.P.	316.419	36.412	30/06/2023
0,10 %	BNY Mellon Asset Management	310.528	43.082	30/06/2023
0,10 %	Victory Capital Management Inc.	308.826	-255	30/06/2023
0,10 %	Goldman Sachs & Company, Inc.	301.753	-18.642	30/06/2023
0,09 %	CM Management, LLC	275.000	125.000	30/06/2023
0,08 %	Jennison Associates LLC	258.300	-17.600	31/08/2023
0,08 %	Northern Trust Global Investments	258.043	100.061	30/06/2023
0,08 %	Boyer Andrew S	244.739	-29.302	11/08/2023
0,08 %	DWS Investment Management Americas, Inc.	241.569	-20.215	30/06/2023
0,08 %	Polen Capital Management, LLC	237.260	0	31/08/2023
0,08 %	Dimensional Fund Advisors, Ltd.	233.175	0	31/08/2023
0,08 %	Neuberger Berman Asset Management Ireland Ltd	232.709	12.910	30/06/2023
0,08 %	Assenagon Asset Management S.A.	231.709	-36.958	30/06/2023
0,07 %	Nark (Theodore C.)	224.318	80.128	10/05/2023
0,07 %	PGIM Fixed Income	222.350	55.500	30/06/2023
0,07 %	Morgan Stanley & Co. LLC	220.914	76.598	30/06/2023
0,06 %	Rhumbline Advisers Ltd. Partnership	198.782	36.597	30/06/2023
0,06 %	State Teachers Retirement System of Ohio	193.200	-30.000	30/06/2023
0,06 %	George (Jeffrey P.)	193.084	80.128	10/05/2023
0,06 %	Algert Global LLC	189.560	-77.242	30/06/2023
0,06 %	Buchi (J Kevin)	185.619	80.128	10/05/2023
0,06 %	Parametric Portfolio Associates LLC	182.290	-23.115	30/06/2023
0,06 %	Kiely (John J.)	179.274	80.128	10/05/2023
0,06 %	Susquehanna International Group, LLP	176.548	124.893	30/06/2023
0,06 %	AllianceBernstein L.P.	175.499	-6.450	30/06/2023
0,06 %	Alva (Emily Peterson)	174.318	80.128	10/05/2023
0,05 %	Los Angeles Capital Management LLC	169.640	-16.156	30/06/2023
0,05 %	Yanai (Shlomo)	169.274	80.128	10/05/2023
0,05 %	Raymond James & Associates, Inc.	161.387	0	30/06/2023
0,05 %	CornerCap Investment Counsel, Inc.	150.013	497	30/06/2023
0,05 %	Stifel Nicolaus Investment Advisors	146.476	462	30/06/2023
0,05 %	GlobeFlex Capital, L.P.	140.203	-8.504	30/06/2023
0,04 %	Alberta Investment Management Corporation	131.267	0	30/06/2023
0,04 %	Vanguard Investments Australia Ltd.	122.549	-13.086	30/06/2023
0,04 %	Fidelity Management & Research Company LLC	121.986	555	30/06/2023
0,04 %	Occudo Quantitative Strategies LP	120.436	1.654	30/06/2023
0,04 %	Aperio Group, LLC	119.661	44.553	30/06/2023
0,04 %	GSA Capital Partners LLP	114.251	33.732	30/06/2023
0,04 %	BofA Global Research (US)	109.941	-16.046	30/06/2023
0,03 %	State of Wyoming	92.770	7.143	30/06/2023
0,03 %	Signature Wealth Management Partners, LLC	87.666	0	30/06/2023
0,03 %	Hedges Asset Management LLC	84.600	0	30/06/2023
0,03 %	Ritholtz Wealth Management LLC	81.288	81.288	30/09/2023
0,02 %	Avantis Investors	76.263	40.976	30/09/2023
0,02 %	T. Rowe Price International Ltd	71.808	51.989	30/06/2023
0,02 %	Tranquilli Financial Advisor LLC	71.414	0	30/06/2023
0,02 %	MetLife Investment Management, LLC	68.810	40.998	30/06/2023
0,02 %	BNP Paribas Securities Corp. North America	65.719	-56.875	30/06/2023
0,02 %	UBS Asset Management (Switzerland)	61.388	0	31/03/2023
0,02 %	Barclays Bank PLC	59.147	-27.846	30/06/2023
0,02 %	SunAmerica Asset Management, LLC	58.673	8.968	30/06/2023
0,02 %	LPL Financial LLC	58.223	-159	30/06/2023
0,02 %	Autor (Deborah M)	54.949	54.949	30/07/2023
0,02 %	Putnam Investment Management, L.L.C.	52.586	-395	31/08/2023
0,02 %	SG Americas Securities, L.L.C.	52.455	52.455	30/09/2023
0,02 %	Florida State Board of Administration	51.990	0	30/06/2023
0,02 %	Private Advisor Group LLC	51.946	0	30/06/2023
0,02 %	Manulife Investment Management (North America) Limited	51.315	6.991	30/06/2023
0,02 %	Osaic Holdings, Inc.	50.805	-5.445	30/06/2023
0,02 %	Principal Global Investors (Equity)	49.340	-12.025	30/06/2023
0,02 %	Voya Investment Management LLC	49.206	7.379	30/06/2023

What values and corporate philosophy does Amneal Pharmaceuticals represent?

Amneal Pharmaceuticals Inc is committed to delivering quality generic pharmaceutical products. Their corporate philosophy revolves around providing affordable, accessible, and innovative healthcare solutions. With a focus on research and development, they strive to improve patient lives and enhance overall well-being. By offering a diverse portfolio of high-quality generic medications, Amneal Pharmaceuticals Inc aims to make healthcare more accessible and contribute to the overall welfare of society. They prioritize excellence, accountability, and integrity, all while aiming to deliver sustainable value to patients, healthcare providers, and other stakeholders.

In which countries and regions is Amneal Pharmaceuticals primarily present?

Amneal Pharmaceuticals Inc is primarily present in the United States.

What significant milestones has the company Amneal Pharmaceuticals achieved?

Amneal Pharmaceuticals Inc has achieved several significant milestones throughout its history. The company has successfully expanded its product portfolio, offering a wide range of generic pharmaceuticals, specialty drugs, and over-the-counter products. Additionally, Amneal Pharmaceuticals Inc has made strategic acquisitions and partnerships to strengthen its global presence and enhance its research and development capabilities. The company has also received multiple approvals from regulatory authorities for its Abbreviated New Drug Applications (ANDAs) and has launched various generic medications in the market. Overall, Amneal Pharmaceuticals Inc has demonstrated continuous growth and innovation, positioning itself as a leading player in the pharmaceutical industry.

What is the history and background of the company Amneal Pharmaceuticals?

Amneal Pharmaceuticals Inc is a prominent pharmaceutical company with a rich history and background. Founded in 2002, the company has grown rapidly to become a leading provider of high-quality generic and specialty pharmaceutical products. Amneal focuses on developing, manufacturing, and distributing a diverse range of innovative and affordable medications to improve patients' lives. With a strong commitment to quality, the company has established a robust portfolio of FDA-approved products and consistently achieves high safety and efficacy standards. Amneal Pharmaceuticals Inc has also expanded globally, operating in multiple countries to serve a wider patient population.

Who are the main competitors of Amneal Pharmaceuticals in the market?

The main competitors of Amneal Pharmaceuticals Inc in the market include major pharmaceutical companies such as Teva Pharmaceutical Industries Ltd, Mylan N.V, and Endo International plc.

In which industries is Amneal Pharmaceuticals primarily active?

Amneal Pharmaceuticals Inc is primarily active in the pharmaceutical industry.

What is the business model of Amneal Pharmaceuticals?

The business model of Amneal Pharmaceuticals Inc is focused on developing, manufacturing, and distributing high-quality generic and specialty pharmaceutical products. Amneal aims to provide affordable and accessible medications to patients worldwide, while adhering to stringent quality standards. The company operates through its robust supply chain, leveraging its extensive manufacturing capabilities and scientific expertise to produce a diverse portfolio of pharmaceutical products. Amneal Pharmaceuticals Inc is dedicated to continuously improving patient outcomes by delivering innovative and cost-effective solutions across therapeutic areas such as cardiovascular, central nervous system, and infectious diseases, among others.

Quale è il P/E di Amneal Pharmaceuticals 2024?

Il P/E (Price/Earnings) di Amneal Pharmaceuticals è 7,07.

Qual è il P/S di Amneal Pharmaceuticals 2024?

Il KUV di Amneal Pharmaceuticals è 0,49.

Quale è il punteggio di qualità AlleAktien di Amneal Pharmaceuticals?

Il Quality Score AlleAktien per Amneal Pharmaceuticals è 5/10.

Quanto è il fatturato di Amneal Pharmaceuticals 2024?

Il fatturato di attesa Amneal Pharmaceuticals è 2,61 miliardi USD.

Qual è il profitto di Amneal Pharmaceuticals 2024?

Il attesa Amneal Pharmaceuticals profitto è 182,60 Mio. USD.

Cosa fa Amneal Pharmaceuticals?

Amneal Pharmaceuticals Inc is an internationally operating company in the pharmaceutical industry that specializes in the development, manufacturing, and marketing of generics and innovative products. The business model is based on a diversified production and sales strategy, which enables the company to be successful in different markets and product categories. The company is active in several segments, including generics, innovative products, specialty pharma, and biosimilars. In the generics segment, the company offers a variety of high-quality generic drugs for different therapeutic areas, which have the same quality and efficacy as the original products. The innovative products include innovative drugs for rare diseases and specialized therapeutic areas. In the specialty pharma segment, the company offers a wide range of drugs for specialized therapies, which are often intended for patients with severe or rare diseases. The biosimilars segment focuses on the development and marketing of biosimilars for various therapy areas, such as oncology. Amneal Pharmaceuticals Inc also offers over-the-counter drugs, dietary supplements, and cosmetics. The company has successfully launched a variety of products in these categories to meet the consumers' needs for self-care products and a healthy lifestyle. Another important aspect of Amneal Pharmaceuticals Inc's business model is the targeted expansion of the company through strategic acquisitions and partnerships. In the past, the company has already made some successful acquisitions of competitors to expand its product portfolio and increase sales. The company places particular emphasis on quality assurance and sustainable business practices. Amneal Pharmaceuticals Inc pursues a comprehensive quality management system that meets the highest requirements and standards. Sustainability also plays an important role in the company's business model. Amneal Pharmaceuticals Inc aims to develop environmentally friendly processes and products to contribute to the protection of the environment. In summary, the business model of Amneal Pharmaceuticals Inc is based on a broad range of products, diversified sales strategies, and targeted expansion and acquisition strategies. The consistent adherence to the highest quality and sustainability standards, as well as the focus on specialty therapies and innovative products, have made the company an important player in the pharmaceutical industry. Only the first and the last sentence are to be written in the answer field.

Quanto ammonta la Amneal Pharmaceuticals Dividende?

Amneal Pharmaceuticals distribuisce un dividendo di 0 USD suddiviso in pagamenti all'anno.

Quante volte paga dividendi Amneal Pharmaceuticals?

La dividendazione per Amneal Pharmaceuticals non può essere attualmente calcolata oppure la società non distribuisce dividendi.

Cos'è la Amneal Pharmaceuticals ISIN?

La ISIN di Amneal Pharmaceuticals è US03168L1052.

Qual è il Amneal Pharmaceuticals WKN?

Il codice WKN di Amneal Pharmaceuticals è A2JLMD.

Qual è il ticker di Amneal Pharmaceuticals?

Il ticker di Amneal Pharmaceuticals è AMRX.

Quanta dividenda paga Amneal Pharmaceuticals?

Nell'ultimo anno, Amneal Pharmaceuticals ha pagato un dividendo di . Questo corrisponde a un rendimento da dividendo di circa . Per i prossimi 12 mesi, Amneal Pharmaceuticals prevede di pagare un dividendo di 0 USD.

Qual è il rendimento del dividendo di Amneal Pharmaceuticals?

La resa dei dividendi di Amneal Pharmaceuticals è attualmente del .

Quando paga Amneal Pharmaceuticals il dividendo?

Amneal Pharmaceuticals paga un dividendo su base trimestrale. Questo viene distribuito nei mesi di .

Quanto è sicura la dividenda di Amneal Pharmaceuticals?

Amneal Pharmaceuticals ha pagato un dividendo ogni anno negli ultimi 0 anni.

Qual è il dividendo di Amneal Pharmaceuticals?

Nei prossimi 12 mesi si prevedono dividendi per un importo di 0 USD. Questo corrisponde a un rendimento da dividendo del 0 %.

In quale settore si trova Amneal Pharmaceuticals?

Amneal Pharmaceuticals è assegnato al settore 'Salute'.

Wann musste ich die Aktien von Amneal Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

Per ricevere l'ultima dividend of Amneal Pharmaceuticals del 01/08/2024 dell'importo di 0 USD, dovevi avere l'azione in portafoglio prima del giorno "Ex" il 01/08/2024.

Quando ha pagato l'ultima dividend Amneal Pharmaceuticals?

La distribuzione dell'ultima dividenda è avvenuta il 01/08/2024.

Qual è stata la dividenda di Amneal Pharmaceuticals nell'anno 2023?

Nell'anno 2023 sono stati distribuiti da Amneal Pharmaceuticals 0 USD come dividendi.

In quale valuta Amneal Pharmaceuticals distribuisce il dividendo?

Le dividende di Amneal Pharmaceuticals vengono distribuite in USD.

1997	1998	1999	2000	2001	2002	2003	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e
0	0	0,00	0,01	0,01	0,02	0,06	0,11	0,14	0,27	0,21	0,36	0,88	0,51	0,58	0,51	0,60	0,86	0,82	0,78	1,66	1,63	1,99	2,09	2,21	2,39	2,61	2,71	2,82	2,74	2,83
-	-	-	900,00	-40,00	300,00	141,67	93,10	20,54	102,22	-23,08	70,48	145,53	-41,75	13,48	-12,05	16,63	44,30	-4,19	-5,95	114,58	-2,22	22,51	5,07	5,69	8,18	9,11	3,68	4,17	-2,77	3,03
-	-	-	-	-50,00	25,00	25,86	48,21	46,67	60,81	56,19	52,51	61,32	50,39	48,54	41,49	52,85	41,74	-18,33	18,45	43,60	29,46	33,28	37,79	35,94	35,77	-	-	-	-	-
0	0	0	0	-3,00	6,00	15,00	54,00	63,00	166,00	118,00	188,00	539,00	258,00	282,00	212,00	315,00	359,00	-151,00	143,00	725,00	479,00	663,00	791,00	795,00	856,00	0	0	0	0	0
-3,00	-5,00	-7,00	-21,00	-25,00	-20,00	-13,00	2,00	1,00	86,00	10,00	85,00	399,00	107,00	97,00	24,00	97,00	87,00	-433,00	-153,00	284,00	-12,00	145,00	216,00	199,00	274,00	569,00	552,00	553,00	420,00	0
-	-	-700,00	-210,00	-416,67	-83,33	-22,41	1,79	0,74	31,50	4,76	23,74	45,39	20,90	16,70	4,70	16,28	10,12	-52,55	-19,74	17,08	-0,74	7,28	10,32	9,00	11,45	21,79	20,39	19,61	15,32	-
-3,00	-5,00	-8,00	-25,00	-25,00	-20,00	-14,00	-5,00	-12,00	125,00	16,00	50,00	250,00	65,00	55,00	101,00	57,00	39,00	-472,00	-469,00	-20,00	-361,00	91,00	10,00	-129,00	-83,00	182,00	203,00	218,00	261,00	289,00
-	66,67	60,00	212,50	-	-20,00	-30,00	-64,29	140,00	-1.141,67	-87,20	212,50	400,00	-74,00	-15,38	83,64	-43,56	-31,58	-1.310,26	-0,64	-95,74	1.705,00	-125,21	-89,01	-1.390,00	-35,66	-319,28	11,54	7,39	19,72	10,73
7,10	7,20	8,00	27,50	41,60	47,40	51,30	59,00	59,00	61,20	60,80	61,10	65,60	67,30	68,40	68,70	70,50	72,00	71,10	71,90	127,30	132,10	148,90	151,82	150,94	176,14	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

1997	1998	1999	2000	2001	2002	2003	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-3,00	-5,00	-8,00	-25,00	-25,00	-20,00	-14,00	-5,00	-12,00	125,00	16,00	50,00	250,00	65,00	55,00	101,00	57,00	39,00	-472,00	-469,00	-201,00	-603,00	68,00	20,00	-254,00	-48,00
0	0	0	6,00	5,00	2,00	3,00	5,00	7,00	8,00	9,00	11,00	12,00	15,00	77,00	36,00	34,00	68,00	88,00	109,00	137,00	207,00	235,00	233,00	240,00	229,00
0	0	0	0	0	0	0	0	0	16,00	3,00	-10,00	42,00	7,00	-23,00	-21,00	-11,00	-29,00	-127,00	74,00	-9,00	371,00	0	0	0	0
0	0	0	-1,00	0	1,00	-5,00	4,00	-24,00	18,00	-1,00	-97,00	82,00	-86,00	37,00	-11,00	-76,00	-19,00	-44,00	-11,00	7,00	-120,00	-61,00	-133,00	-59,00	-47,00
0	0	1,00	4,00	0	0	-3,00	17,00	23,00	-49,00	36,00	38,00	-138,00	4,00	-41,00	44,00	29,00	33,00	639,00	380,00	484,00	168,00	157,00	150,00	171,00	238,00
0	0	0	0	0	0	1,00	2,00	3,00	4,00	3,00	0	0	0	0	0	0	15,00	18,00	28,00	131,00	158,00	130,00	121,00	142,00	192,00
0	0	0	0	0	0	0	0	0	14,00	8,00	0	129,00	24,00	55,00	34,00	72,00	43,00	23,00	2,00	-35,00	10,00	100,00	-15,00	-12,00	-2,00
-2,00	-3,00	-6,00	-16,00	-17,00	-15,00	-19,00	21,00	-5,00	119,00	64,00	-8,00	249,00	6,00	105,00	149,00	32,00	92,00	83,00	84,00	250,00	1,00	379,00	241,00	65,00	345,00
-1,00	-1,00	0	-3,00	-16,00	-15,00	-4,00	-14,00	-21,00	-18,00	-25,00	-14,00	-16,00	-30,00	-171,00	-44,00	-42,00	-31,00	-52,00	-26,00	-97,00	-97,00	-66,00	-52,00	-90,00	-69,00
2,00	-1,00	0	-11,00	-29,00	5,00	-4,00	35,00	-43,00	-98,00	32,00	-21,00	-213,00	-15,00	-85,00	-115,00	-16,00	-467,00	-627,00	-9,00	-396,00	-19,00	-317,00	-194,00	-174,00	-69,00
3,00	0	1,00	-7,00	-12,00	20,00	0	50,00	-22,00	-79,00	58,00	-7,00	-197,00	15,00	85,00	-71,00	26,00	-436,00	-574,00	17,00	-299,00	77,00	-251,00	-141,00	-83,00	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	3,00	6,00	3,00	-27,00	0	0	-65,00	-12,00	0	0	0	0	0	453,00	395,00	-70,00	541,00	-29,00	143,00	-79,00	-38,00	22,00
3,00	2,00	12,00	31,00	25,00	7,00	25,00	0	0	0	0	5,00	17,00	14,00	12,00	8,00	11,00	99,00	9,00	1,00	3,00	1,00	0	0	0	0
3,00	2,00	12,00	31,00	50,00	5,00	28,00	-29,00	0	10,00	-65,00	-7,00	23,00	21,00	17,00	9,00	14,00	500,00	382,00	-73,00	287,00	-45,00	131,00	-138,00	-106,00	-212,00
0	0	0	0	22,00	-9,00	0	-2,00	0	10,00	0	0	6,00	6,00	4,00	0	3,00	-51,00	-21,00	-5,00	-74,00	-18,00	-11,00	-59,00	-69,00	-235,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-183,00	0	0	0	0	0
2,00	-2,00	7,00	4,00	3,00	-4,00	5,00	26,00	-49,00	31,00	31,00	-37,00	60,00	12,00	37,00	42,00	30,00	125,00	-160,00	1,00	140,00	-65,00	194,00	-90,00	-221,00	63,00
-4,10	-5,10	-7,20	-19,60	-34,50	-30,30	-23,60	6,40	-27,30	100,20	38,70	-22,60	233,50	-24,40	-65,90	105,10	-10,10	61,50	31,00	57,40	153,10	-95,70	312,80	189,18	-25,50	276,39
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Emissioni dirette	—
Emissioni indirette da energia acquistata	—
Emissioni indirette all'interno della catena del valore	—
Emissioni di CO₂	—
Strategia di riduzione della CO₂	✅
Energia a carbone	❌
energia nucleare	❌
Esperimenti sugli animali	✅
Pelliccia & Pelle	—
Pesticidi	—
Olio di palma	—
Tabacco	❌
Biotecnologia	❌
Concetto climatico	—
Silvicoltura sostenibile	—
Normative sul riciclaggio	❌
Imballaggio ecologico	❌
Sostanze pericolose	❌
Consumo e efficienza del carburante	❌
Consumo ed efficienza idrica	❌

Percentuale di donne impiegate	—
Percentuale di donne in posizioni manageriali	—
Percentuale di dipendenti asiatici	—
Quota di management asiatico	—
Percentuale di impiegati ispanici/latini	—
Quota di management ispanico/latino	—
Quota di dipendenti di colore	—
Percentuale di management di colore	—
Quota di impiegati bianchi	—
Percentuale di management bianco	—
Contenuti per adulti	❌
Alcol	❌
Armamento	—
armi da fuoco	❌
Gioco d'azzardo	❌
Contratti militari	❌
Concetto dei diritti umani	✅
Concetto di protezione dei dati	—
Sicurezza sul lavoro e salute	✅
Cattolico	✅

Rapporto di sostenibilità	❌
Engagement degli Stakeholder	❌
Politiche di richiamo	❌
Diritto antitrust	❌

Amneal Pharmaceuticals Ticker	Amneal Pharmaceuticals FIGI
AMRX:US	BBG00462PGG0
AMRX:UA	BBG00JPC9DM2
AMRX:UN	BBG00JPC9DP9
AMRX:UP	BBG00JPC9DQ8
AMRX:UB	BBG00JPC9DS6
AMRX:UM	BBG00JPC9DV2
AMRX:UX	BBG00JPC9DW1
AMRX:UD	BBG00JPC9F10
AMRX:UW	BBG00JPC9F38
AMRX:UF	BBG00JPC9F47
AMRX:VY	BBG00JPC9F56
AMRX:VJ	BBG00JPC9F65
AMRX:VK	BBG00JPC9F74
AMRX:VF	BBG00JPC9F83
AMRXEUR:XS	BBG00KVTDHX9
AMRXEUR:XH	BBG00KVTDJ01
AMRXEUR:XF	BBG00KVTDJ29
AMRXEUR:XE	BBG00KVTDJ47
AMRXEUR:XJ	BBG00KVTDJ56
AMRXEUR:XL	BBG00KVTDJ65
AMRXEUR:XG	BBG00KVTDJ74
AMRXEUR:XO	BBG00KVTDJ83
AMRXEUR:XA	BBG00KVTDJD7
AMRXEUR:E1	BBG00KVTDJF5
AMRXEUR:XT	BBG00KVTDJG4
AMRXEUR:XW	BBG00KVTDJH3
AMRXEUR:XU	BBG00KVTDJJ1
AMRXEUR:XV	BBG00KVTDJK9
AMRXEUR:XM	BBG00KVTDJL8
AMRXEUR:XQ	BBG00KVTDJN6
AMRXEUR:XX	BBG00KVTDJP4
AMRXEUR:XZ	BBG00KVTDJQ3
AMRXEUR:EU	BBG00KVTDJS1
2DT:GR	BBG00KXXKCL4
2DT:GF	BBG00KXXKCM3
2DT:GD	BBG00KXXKCN2
2DT:GS	BBG00KXXKCQ9
2DT:GM	BBG00KXXKCR8
2DT:GB	BBG00KXXKCS7
AMRX:UC	BBG00KY7P4Y9
AMRXUSD:EP	BBG00QZ0K402
AMRXUSD:EZ	BBG00QZ0K420
AMRXUSD:XS	BBG00QZ0K439
AMRXUSD:X2	BBG00QZ0K448
AMRXUSD:XH	BBG00QZ0K466
AMRXUSD:XF	BBG00QZ0K484
AMRXUSD:XE	BBG00QZ0K4B0
AMRXUSD:XJ	BBG00QZ0K4C9
AMRXUSD:XL	BBG00QZ0K4D8
AMRXUSD:XG	BBG00QZ0K4F6
AMRXUSD:XO	BBG00QZ0K4G5
AMRXUSD:XA	BBG00QZ0K4L9
AMRXUSD:E1	BBG00QZ0K4M8
AMRXUSD:XT	BBG00QZ0K4N7
AMRXUSD:XW	BBG00QZ0K4P5
AMRXUSD:XU	BBG00QZ0K4Q4
AMRXUSD:XV	BBG00QZ0K4S2
AMRXUSD:XM	BBG00QZ0K4T1
AMRXUSD:XQ	BBG00QZ0K4V8
AMRXUSD:XX	BBG00QZ0K4W7
AMRXUSD:XZ	BBG00QZ0K4X6
AMRXUSD:X1	BBG00QZ0K4Z4
AMRXUSD:EU	BBG00QZ0K527
2DT:TH	BBG00R0SK103
2DT:QT	BBG00R0WGV67
AMRXEUR:EP	BBG00R0Z41S5
AMRXEUR:EZ	BBG00R0Z41V1
AMRXGBP:EP	BBG00R3MXFN3
AMRXGBP:EZ	BBG00R3MXFQ0
AMRXGBP:XS	BBG00R3MXFR9
AMRXGBP:X2	BBG00R3MXFS8
AMRXGBP:XH	BBG00R3MXFV4
AMRXGBP:XF	BBG00R3MXFX2
AMRXGBP:XE	BBG00R3MXFZ0
AMRXGBP:XJ	BBG00R3MXG06
AMRXGBP:XL	BBG00R3MXG15
AMRXGBP:XG	BBG00R3MXG24
AMRXGBP:XO	BBG00R3MXG33
AMRXGBP:XA	BBG00R3MXG79
AMRXGBP:E1	BBG00R3MXG88
AMRXGBP:XT	BBG00R3MXG97
AMRXGBP:XW	BBG00R3MXGB4
AMRXGBP:XU	BBG00R3MXGC3
AMRXGBP:XV	BBG00R3MXGF0
AMRXGBP:XM	BBG00R3MXGG9
AMRXGBP:XQ	BBG00R3MXGH8
AMRXGBP:XX	BBG00R3MXGJ6
AMRXGBP:XZ	BBG00R3MXGK4
AMRXGBP:X1	BBG00R3MXGM2
AMRXGBP:EU	BBG00R3MXGP9
AMRX:VG	BBG00X1P69B2
AMRX:VP	BBG00X1SMPN9
2DT:GZ	BBG012BD0020
2DT:LA	BBG018H9LH20
2DT:LU	BBG018J380X9

Borsa	Amneal Pharmaceuticals Ticker
DÜSSELDORF	2DT.DU
FRANCOFORTE	2DT.F
MONACO	2DT.MU
NEW YORK	AMRX

Fai gli investimenti migliori della tua vita. fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Quotazione

Quotazione

TickerAMRX

ISINUS03168L1052

WKNA2JLMD

Amneal Pharmaceuticals Azione Fatturato, EBIT, Utile US03168L1052 · A2JLMD

Fatturato, Profitto & EBIT

Comprensione di Fatturato, EBIT e Reddito

Analisi annuale e confronti

Utilizzo delle aspettative di investimento

Insights sull'investimento

Amneal Pharmaceuticals Ricavi, Utili e Storia dell'EBIT

Amneal Pharmaceuticals Dati Azionari

GuV

Fatturato e Crescita

Margine Lordo

EBIT e Margine EBIT

Reddito e Crescita

Azioni in Circolazione

Interpretazione del Confronto Annuale

Aspettative e Previsioni

Bilancio

Comprensione del bilancio

Attività

Passività

Patrimonio netto

Analisi anno-per-anno

Interpretazione dei dati

Amneal Pharmaceuticals Margine Azionario US03168L1052 · A2JLMD

Margine

Comprensione del margine lordo

Analisi del margine EBIT

Intuizioni sul margine di vendita

Interpretare le aspettative

Analisi comparativa

Amneal Pharmaceuticals Storico dei margini

Amneal Pharmaceuticals Azione Fatturato, EBIT, Utile per Azione US03168L1052 · A2JLMD

Fatturato, EBIT e Utile per Azione

Fatturato per Azione

EBIT per Azione

Reddito per Azione

Valori Previsti

Amneal Pharmaceuticals Ricavi, utile e EBIT per azione Storico

Amneal Pharmaceuticals Azione e analisi azionaria

Amneal Pharmaceuticals Valutazione secondo il P/E storico, EBIT e P/S

Amneal Pharmaceuticals Numero di azioni US03168L1052 · A2JLMD

Fatturato, EBIT e Utile per Azione

Fatturato per Azione

EBIT per Azione

Reddito per Azione

Valori Previsti

Amneal Pharmaceuticals Stime degli Utili

Amneal Pharmaceuticals Sorprese sugli utili

Rating Eulerpool ESG per l'azione Amneal Pharmaceuticals

Eulerpool World ESG Rating (EESG©)

33/ 100

🌱 Environment

👫 Social

🏛️ Governance

Ambiente (Environment)

Sociale (Social)

Governance aziendale (Governance)

Amneal Pharmaceuticals Struttura degli azionisti

Amneal Pharmaceuticals Consiglio di amministrazione e consiglio di sorveglianza

Domande frequenti sull'azione Amneal Pharmaceuticals